New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
08:34 EDTJECJacobs Engineering attractive after pullback, says Sterne Agee
After Jacobs Engineering reported 1H results that Sterne Agee views as disappointing, the firm remains confident in the company's fundamentals and its ability to accelerate its EPS growth. The firm recommends that investors looking to exploit the upcoming energy/infrastructure cycle add to their positions in the name. It keeps an $80 price target and Buy rating on the stock.
News For JEC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
07:45 EDTJECJacobs Engineering receives contract from Bristol-Myers
Jacobs Engineering (JEC) received a contract from Bristol-Myers Squibb Company (BMY) to provide construction management services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland. Jacobs is also providing architectural and engineering services for the facility, which is being built to produce multiple therapies for the company’s robust and growing portfolio of approved and investigational biologic medicines, and to increase Bristol-Myers Squibb’s biologics manufacturing capacity. The new facility is expected to include multiple large scale bioreactors, a purification area, as well as office and laboratory space. Bristol-Myers Squibb’s Board of Directors has approved initial funding that will support the first phase of the project, with the full cost of the facility expected to be finalized in the second half of 2015. The facility is estimated to be operational in 2019.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use